Horie Shigeo
Department of Urology, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-ku, Tokyo, 173-8605, Japan.
Clin Exp Nephrol. 2005 Dec;9(4):282-291. doi: 10.1007/s10157-005-0367-6.
Autosomal-dominant polycystic kidney disease (ADPKD) is a common hereditary disease that features multiple cystogenesis in various organs and vascular defects. The genes responsible for ADPKD, PKD1, and PKD2 have been identified, and the pathological processes of the disease are becoming clearer. This review focuses on recent findings about the molecular and cellular biology of ADPKD, and especially on PKD1. PKD1 and its product, polycystin-1, play pivotal roles in cellular differentiation because they regulate the cell cycle and because polycystin-1 is a component of adherens junctions. A possible link between polycystin-1 and PPARgamma is discussed. The extraordinarily fast research progress in this area in the last decade has now reached a stage where the development of a remedy for ADPKD might become possible in the near future.
常染色体显性多囊肾病(ADPKD)是一种常见的遗传性疾病,其特征是多个器官出现多发性囊肿形成和血管缺陷。导致ADPKD的基因PKD1和PKD2已被确定,该疾病的病理过程也越来越清晰。本综述重点关注ADPKD分子和细胞生物学的最新研究发现,特别是关于PKD1的研究。PKD1及其产物多囊蛋白-1在细胞分化中起关键作用,因为它们调节细胞周期,且多囊蛋白-1是黏附连接的一个组成部分。文中还讨论了多囊蛋白-1与过氧化物酶体增殖物激活受体γ(PPARγ)之间可能存在的联系。过去十年该领域极其快速的研究进展现已达到一个阶段,即在不久的将来有可能开发出针对ADPKD 的治疗方法。